How Does Spedra Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Spedra Works

  • Primary Action: Highly selective PDE5 enzyme inhibition (100-fold selectivity over PDE6)
  • Chemical Effect: Increases cyclic guanosine monophosphate (cGMP) levels in penile tissue
  • Physiological Result: Relaxes smooth muscle cells in penile arteries, boosting blood flow
  • Fast Onset: Can work in as little as 15–30 minutes for some men
  • Duration: Effects last up to 6 hours, with a half-life of 5–10 hours
  • Requirement: Sexual stimulation is essential to trigger nitric oxide release

Spedra (avanafil) is a modern PDE5 inhibitor designed for rapid absorption and high selectivity. It enhances the body's natural response to sexual stimulation, helping men with erectile dysfunction achieve and maintain erections suitable for sexual activity. Below we explain the detailed science behind how it works.

Important Medical Advice

If you experience an erection lasting more than 4 hours (priapism), sudden vision loss, or chest pain while taking Spedra, seek immediate medical attention. Do not take Spedra with nitrate medications (e.g., glyceryl trinitrate) as this can cause dangerously low blood pressure.

Chemical Composition & Molecular Structure

Avanafil, the active ingredient in Spedra, is a pyrimidine derivative specifically engineered for potent and selective PDE5 inhibition.

Chemical Structure Details

Chemical Name

(S)-2-(2-aminopyrimidin-4-yl)-4-(3-chloro-4-methoxybenzylamino)-2-isopropylbutanenitrile

This structure contains a pyrimidine ring and a chloro-methoxybenzyl group, conferring high selectivity for PDE5.

Molecular Formula

C23H26ClN7O3

23 carbon, 26 hydrogen, 1 chlorine, 7 nitrogen, and 3 oxygen atoms.

Molecular Weight

484.0 g/mol (free base)

The molecular weight influences its absorption and tissue distribution.

Key Pharmaceutical Properties

PropertyValue/CharacteristicClinical Significance
SolubilityPoorly soluble in water, but formulation enhances absorptionRapid dissolution in gastrointestinal tract
pKaApprox. 4.5 (weak base)Affects ionisation and permeability at physiological pH
Protein Binding~99% bound to plasma proteinsHigh binding influences drug interactions and distribution
SelectivityPDE5 vs PDE6: ~100-foldMinimal visual side effects compared to older PDE5 inhibitors

🗒️ Pharmaceutical Insight: The unique chloro-methoxybenzyl group in avanafil contributes to its high lipophilicity and rapid tissue penetration, enabling fast onset of action.

Mechanism of Action: How Spedra Creates an Erection

Avanafil works by amplifying the natural erectile pathway through targeted PDE5 inhibition in penile tissue.

The Normal Erection Pathway

  1. Sexual Stimulation: Nerves release nitric oxide (NO) in penile tissue
  2. Enzyme Activation: NO activates guanylate cyclase enzyme
  3. cGMP Production: Guanylate cyclase produces cyclic GMP (cGMP)
  4. Smooth Muscle Relaxation: cGMP causes relaxation of penile arteries
  5. Increased Blood Flow: Blood enters corpora cavernosa, creating erection
  6. Natural Breakdown: PDE5 enzyme normally breaks down cGMP, ending erection

Spedra's Intervention

StepNormal ProcessSpedra Effect
1. NO ReleaseSexual stimulation triggers nitric oxide releaseSpedra doesn't affect this step – requires natural stimulation
2. cGMP ProductionGuanylate cyclase produces cGMPNormal production continues unaffected
3. PDE5 ActionPDE5 breaks down cGMP, limiting erection durationSpedra blocks PDE5, preventing cGMP breakdown
4. ResultLimited cGMP leads to weaker/shorter erectionsEnhanced cGMP levels support stronger, longer-lasting erections

🗒️ Physiological Insight: Avanafil has a higher selectivity for PDE5 than sildenafil, meaning fewer off-target effects (like facial flushing or visual disturbances) at therapeutic doses.

Enzyme Inhibition: Targeting Phosphodiesterase Type 5

Avanafil's effectiveness stems from its competitive, reversible inhibition of PDE5, an enzyme concentrated in penile smooth muscle, lungs, and platelets.

Enzyme Inhibition Characteristics

Inhibition Type

Competitive Reversible Inhibition

Avanafil competes with cGMP for the catalytic site of PDE5, blocking cGMP hydrolysis.

Binding Affinity

IC50 ≈ 5.2 nM

Very high affinity for PDE5, meaning potent inhibition at low concentrations.

Selectivity Ratio

PDE5:PDE6 ≈ 100:1

100 times more selective for PDE5 than PDE6, virtually eliminating blue-tinted vision side effects.

Selectivity Across Phosphodiesterase Enzymes

PDE Enzyme TypeTissue LocationAvanafil SelectivityClinical Relevance
PDE5Penile tissue, lungs, blood vesselsHigh (Primary target)Erectile dysfunction treatment
PDE6Retina (eye)Very low (100x less than PDE5)Minimal visual disturbances
PDE1Brain, heartVery lowNo significant cardiac effects
PDE11Testes, skeletal muscleNegligibleUnlikely to affect fertility or muscle

🗒️ Biochemical Insight: The high selectivity of avanafil for PDE5 means that at recommended doses (50–200 mg), side effects related to PDE6 inhibition (like chromatopsia) are extremely rare.

Metabolic Effects and Duration in the Body

Avanafil undergoes hepatic metabolism to form active and inactive metabolites, determining its duration of action.

Metabolic Pathway

Primary Metabolism

Location: Liver (mainly CYP3A4 enzyme)

Process: Oxidation and dealkylation

Result: Forms active metabolite M4 (approx. 3% potency of parent)

Secondary Metabolism

Enzymes: CYP2C9 minor role

Process: Further oxidation to inactive metabolites

Result: Water-soluble compounds for excretion

Elimination

Route: ~60% faeces, ~20% urine

Half-life: 5–10 hours (mean 6.7 hours)

Active Metabolite: M4 contributes minimally to overall effect

Timeline of Effects After 100mg Dose

  1. 0–30 minutes: Rapid absorption, detectable in blood within 15–20 minutes
  2. 30–45 minutes: Peak plasma concentration (fasting); optimal time for sexual activity
  3. 45 minutes – 6 hours: Therapeutic PDE5 inhibition maintained; gradual decline
  4. 6–12 hours: Residual effects possible but diminishing
  5. 12–24 hours: Complete elimination in most individuals

🗒️ Clinical Correlation: A high-fat meal can delay absorption by approximately 1 hour and reduce peak concentration by 24%, so taking Spedra on an empty stomach is recommended for fastest onset.

Absorption, Distribution & Elimination

Avanafil's pharmacokinetic profile supports its use as an on-demand treatment with rapid onset and predictable duration.

Pharmacokinetic Profile

Absorption

Bioavailability: ~30% oral absorption

Peak Time: 30–45 minutes (fasting)

Food Effect: High-fat meal delays Tmax by ~1h, reduces Cmax by 24%

Distribution

Volume of Distribution: 30–40 L

Protein Binding: 99% (mainly albumin)

Tissue Penetration: Rapid into penile tissue due to lipophilicity

Elimination

Half-life: 5–10 hours

Renal Excretion: 20% as metabolites

Fecal Excretion: 60% as metabolites

Special Population Considerations

PopulationEffect on AvanafilDosing Consideration
Elderly (≥65 years)Modestly increased exposureStart with 50mg, titrate as tolerated
Renal Impairment (severe)Limited data, but no significant accumulation expectedUse with caution, starting dose 50mg
Hepatic Impairment (moderate)Increased AUC (30–50%)Max dose 50mg per day; avoid in severe impairment
CYP3A4 Inhibitors (e.g., ketoconazole)Significantly increased exposure (up to 13-fold)Contraindicated with strong CYP3A4 inhibitors; with moderate inhibitors (e.g., erythromycin), max 100mg every 2 days

🗒️ Clinical Warning: Grapefruit juice (a moderate CYP3A4 inhibitor) should be avoided within 24 hours of taking Spedra, as it can increase avanafil levels and side effects.

Clinical Efficacy for Erectile Dysfunction

Clinical studies demonstrate that avanafil is effective across a broad range of men with erectile dysfunction, including those with diabetes and after prostatectomy.

Efficacy Data from Clinical Studies

ED Type/CauseSpedra Efficacy Rate (100–200mg)Study Details
General ED population70–80% successful intercourse attemptsPooled analysis of phase III trials
Diabetes-related ED65–75% improvementSignificant over placebo, even with poor glycaemic control
Post-prostatectomy ED50–60% response rateBest results in nerve-sparing surgery
Severe ED (IIEF score <11)~60% success200mg dose most effective

Optimal Use Guidelines Based on Mechanism

  1. Timing: Take 30 minutes before sexual activity; can be taken as early as 15 minutes before for some men
  2. Dose: Start with 100mg, adjust to 50mg (if side effects) or 200mg (if insufficient response)
  3. Food: Avoid high-fat meals near dosing time for fastest effect
  4. Stimulation: Sexual arousal essential – Spedra does not work without it
  5. Frequency: Maximum once daily; when used with moderate CYP3A4 inhibitors, allow 48 hours between doses
  6. Contraindications: Strictly avoid nitrates, strong CYP3A4 inhibitors (e.g., ketoconazole, HIV protease inhibitors)

🗒️ Prescribing Insight: Avanafil's rapid onset and high selectivity make it a good choice for men who want spontaneity and minimal side effects. Always review concomitant medications for potential interactions.

Spedra Mechanism FAQs

Spedra can start working in as little as 15–30 minutes for some men. Maximum effectiveness is usually reached within 30–45 minutes when taken on an empty stomach.

No, Spedra only works if you are sexually aroused. It enhances the natural response to stimulation but does not cause automatic erections.

Yes, but a high-fat meal may delay absorption by about an hour and slightly reduce effectiveness. For fastest results, take it on an empty stomach.

Spedra is about 100 times more selective for PDE5 than PDE6 (the enzyme in the retina), so it rarely causes the blue-tinted vision associated with other PDE5 inhibitors.

The effects of Spedra typically last up to 6 hours, although individual response may vary. The half-life is 5–10 hours, so some benefit may persist longer.

Need Treatment for Erectile Dysfunction?

If you're experiencing erectile dysfunction and want to know if Spedra could be right for you, speak with a UK-registered doctor through a confidential online consultation.

Secure Prescription & Next-Day Delivery

MHRA-compliant | GPhC-registered pharmacy | Discreet packaging | UK-registered doctors

Start ED Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 14 February 2026

Next Review: 14 August 2026

Published on: 14 February 2026

Last Updated: 14 February 2026